Upcoming Public Workshop on Reducing the Risk of Preventable Adverse Drug Events Associated with Hypoglycemia in the Older Population

Share

September 12, 2017 9:00 a.m. – 4:00 p.m. ET | Register

The Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research, Professional Affairs and Stakeholder Engagement Staff, is hosting a one day public workshop entitled “Reducing the Risk of Preventable Adverse Drug Events Associated with Hypoglycemia in the Older Population.” During the workshop, public and federal partners will discuss:

  • The importance of individualizing glycemic control targets for older patients with diabetes
  • Risk reduction for serious hypoglycemia
  • Medication safety efforts, both those that are a part of FDA’s Safe Use Initiative and those external to the FDA, that are relevant and important to older adults living with diabetes
  • Future areas of research

The National Action Plan for Adverse Drug Event Prevention identifies hypoglycemia as a common, clinically significant, and preventable adverse effect from diabetes agents that can cause serious harm to patients. Individualized glycemic control targets can reduce risk of hypoglycemia, especially in older adults. Health care providers can learn how to implement individualized approaches to diabetes care in ODPHP’s free eLearning course, “Preventing Adverse Drug Events: Individualizing Glycemic Targets Using Health Literacy Strategies.”

The workshop will take place at FDA’s White Oak Campus located at:
10903 New Hampshire Avenue
Building 31 (The Great Room)
Silver Spring, MD 20903

All attendees must register for the event. More information is available through the Federal Register.

Share